Cargando…
Antibody Responses in COVID-19: A Review
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to spread worldwide as a severe pandemic. Although its seroprevalence is highly variable among territories, it has been reported at around 10%, but higher in health workers. Evidence regarding cross-neutralizing response betw...
Autores principales: | Chvatal-Medina, Mateo, Mendez-Cortina, Yorjagis, Patiño, Pablo J., Velilla, Paula A., Rugeles, Maria T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8081880/ https://www.ncbi.nlm.nih.gov/pubmed/33936045 http://dx.doi.org/10.3389/fimmu.2021.633184 |
Ejemplares similares
-
Dynamics of humoral immune response in SARS-CoV-2 infected individuals with different clinical stages
por: Mendez-Cortina, Yorjagis, et al.
Publicado: (2022) -
Humoral Response to BNT162b2 Vaccine Against SARS-CoV-2 Variants Decays After Six Months
por: Lopera, Tulio J., et al.
Publicado: (2022) -
Biological sex and age-related differences shape the antiviral response to SARS-CoV-2 infection
por: Montaño Mendoza, Vicky Margarita, et al.
Publicado: (2023) -
Neutralizing antibody titers to Omicron six months after vaccination with BNT162b2 in Colombia
por: Zapata-Cardona, María I., et al.
Publicado: (2022) -
CD8(+) T-Cell Response to HIV Infection in the Era of Antiretroviral Therapy
por: Perdomo-Celis, Federico, et al.
Publicado: (2019)